Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers

por Thaler, Avner, Omer, Nurit, Giladi, Nir, Gurevich, Tanya, Bar-Shira, Anat, Gana-Weisz, Mali, Goldstein, Orly, Kestenbaum, Meir, Shirvan, Julia C., Cedarbaum, Jesse M., Orr-Urtreger, Avi, Regev, Keren, Shenhar-Tsarfaty, Shani, Mirelman, Anat
Publicado 2021

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI

por Huh, Young Eun, Park, Hyejung, Chiang, Ming Sum Ruby, Tuncali, Idil, Liu, Ganqiang, Locascio, Joseph J., Shirvan, Julia, Hutten, Samantha J., Rotunno, Melissa S., Viel, Catherine, Shihabuddin, Lamya S., Wang, Bing, Sardi, Sergio Pablo, Scherzer, Clemens R.
Publicado 2021

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity

por Omer, Nurit, Giladi, Nir, Gurevich, Tanya, Bar‐Shira, Anat, Gana‐Weisz, Mali, Glinka, Tal, Goldstein, Orly, Kestenbaum, Meir, Cedarbaum, Jesse M., Mabrouk, Omar S., Fraser, Kyle B., Shirvan, Julia C., Orr‐Urtreger, Avi, Mirelman, Anat, Thaler, Avner
Publicado 2021